Shopping Cart
- Remove All
- Your shopping cart is currently empty
Anti-SARS-CoV-2 Spike mAb (CR3022) is a human monoclonal IgG1 antibody produced from CHO cells, which specifically targets the S1 domain of the Spike protein in both SARS-CoV and SARS-CoV-2.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | Inquiry | Backorder |
Description | Anti-SARS-CoV-2 Spike mAb (CR3022) is a human monoclonal IgG1 antibody produced from CHO cells, which specifically targets the S1 domain of the Spike protein in both SARS-CoV and SARS-CoV-2. |
In vitro | CR3022 identifies and binds to a concealed epitope on the spike (S) protein, which is only exposed in its open conformations[1]. Moreover, CR3022 exhibits a stronger affinity for SARS-CoV over SARS-CoV-2 due to the presence of a specific glycan in its epitope that is absent in SARS-CoV-2[2]. |
Alias | Anti-SARS-CoV-2 Spike mAb (CR3022) |
Relative Density. | no data available |
Storage | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.